Human trial
Primary evidence or regulator source
Small healthy-human metabolism pilot
Reported findings. Metabolite observations
Nonresponse. Cognition/longevity benefit not demonstrated
Harms. Small short study does not establish long-term safety
Limits. No transfer to other routes/formulations/indications; clinician review pending.
Preparation: Direct NAD+, not NR or NMN Route: intravenous
Read original source ↗Editorial review 2026-10-09. Clinician review pending.